Cell Source, Inc. Contracts & Agreements

94 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Secured Convertible Note dated as of June 24, 2025 issued by Cell Source, Inc. to Quick Capital, LLC
Cell Source, Inc.
Biotechnology
2026
Original Issue Discount Note dated July 7, 2025 issued to Solomon Zolty Investment ULC
Cell Source, Inc.
Biotechnology
2026
Form of Warrant issued to purchasers of 20% Original Issue Discount Convertible Notes
Cell Source, Inc.
Biotechnology
2026
Form of 20% Original Issue Discount Convertible Note
Cell Source, Inc.
Biotechnology
2026
Form of Securities Purchase Agreement between the Company and purchasers of 20% Original Issue Discount Convertible Notes
Cell Source, Inc.
Biotechnology
2026
Form of Warrant issued to purchasers of Original Issue Discount Notes
Cell Source, Inc.
Biotechnology
2026
Original Issue Discount Note dated July 7, 2025 issued to Helen Samuels Investment ULC
Cell Source, Inc.
Biotechnology
2026
Original Issue Discount Note dated July 7, 2025 issued to Honey Kamenetsky Investment ULC
Cell Source, Inc.
Biotechnology
2026
Original Issue Discount Note dated July 7, 2025 issued to Phyllis Friedman Investment ULC
Cell Source, Inc.
Biotechnology
2026
Original Issue Discount Note dated July 7, 2025 issued to David Zolty Investment ULC
Cell Source, Inc.
Biotechnology
2026
Business Loan Agreement dated as of March 12, 2026 between Cell Source, Inc. and Cash Village Holdings LLC
Cell Source, Inc.
Biotechnology
2026
Original Issue Discount Note dated July 7, 2025 issued to Darlene Soave Revocable Trust
Cell Source, Inc.
Biotechnology
2026
Amendment No. 5 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
Biotechnology
2026
Amendment No. 6 to Third Amended and Restated Note
Cell Source, Inc.
Biotechnology
2026
Amendment No. 3 to 10% Convertible Note
Cell Source, Inc.
Biotechnology
2026
Amendment No. 4 to 10% Convertible Note
Cell Source, Inc.
Biotechnology
2026
Business Loan Agreement dated as of December 6, 2024 between Cell Source, Inc. and TVT Capital Source LLC
Cell Source, Inc.
Biotechnology
2026
Promissory Note dated December 30, 2024 issued by Cell Source, Inc. to 1800 Diagonal Lending LLC
Cell Source, Inc.
Biotechnology
2026
Note Purchase Agreement dated as of June 24, 2025 between the Company and Quick Capital, LLC
Cell Source, Inc.
Biotechnology
2026
Security Agreement dated as of June 24, 2025 between the Company and Quick Capital, LLC
Cell Source, Inc.
Biotechnology
2026
Registration Rights Agreement between the Company and purchasers of 20% Original Issue Discount Convertible Notes
Cell Source, Inc.
Biotechnology
2026
Stock Purchase Agreement between Cell Source, Inc. and Multiple Canadian Investment ULCs (August 20, 2024)
Purchase Agreements
Cell Source, Inc.
Biotechnology
2024
Amendment No. 3 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2024
Amendment No. 2 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Phyllis Friedman Investment ULC (May 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Helen Samuel Investment ULC (May 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Honey Kamenetsky Investment ULC (May 22, 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Solomon Zolty Investment ULC (May 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with David Zolty Investment ULC (May 22, 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Cell Source, Inc. Original Issue Discount Promissory Note with Darlene Soave Revocable Trust (May 22, 2024)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2024
Amendment No. 1 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 1 to 10% Convertible Note between Cell Source, Inc. and Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 3 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave Revocable Trust
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Amendment No. 2 to Third Amended and Restated 10% Convertible Note between Cell Source, Inc. and Darlene Soave
Note Agreements
Cell Source, Inc.
Biotechnology
2023
Description of Common Stock of Cell Source, Inc.
Stock Agreements
Cell Source, Inc.
Biotechnology
2022
Fifth Amendment to Research and License Agreement between Yeda Research and Development Company Ltd. and Cell Source Limited
License Agreements
Cell Source, Inc.
Biotechnology
2022
Amendment No. 2 to Sponsored Research Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2022
Eighth Amendment to Research and License Agreement between Yeda Research and Development Company Ltd. and Cell Source Limited
License Agreements
Cell Source, Inc.
Biotechnology
2022
Cell Source, Inc. 10.0% Convertible Note Agreement with George Verstraete dated March 9, 2022
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2022
Cell Source, Inc. Third Amended and Restated 10.0% Convertible Note with Darlene D. Soave
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Cell Source, Inc. Warrant to Purchase Common Stock Agreement with Darlene Soave
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2021
Second Amended and Restated 10.0% Convertible Note between Cell Source, Inc. and Darlene D. Soave
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2021
Seventh Amendment to Research and License Agreement between Yeda Research and Development Company Ltd. and Cell Source Limited
License Agreements
Cell Source, Inc.
Biotechnology
2021
Note Exchange Agreement between Cell Source, Inc. and [Holder] Dated February 4, 2021
Exchange Agreements
Cell Source, Inc.
Biotechnology
NV
2021
Cell Source, Inc. Warrant to Purchase 200,000 Shares of Common Stock (Advisory Agreement Related)
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. 2019 Equity Incentive Plan Stock Option Agreement with Participant
Warrant Agreements
Cell Source, Inc.
Biotechnology
NV
2020
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. 8.0% Convertible Note Agreement with Lender (October 2020)
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Cell Source, Inc. 2019 Israeli Equity Incentive Sub-Plan Stock Option Agreement (October 2020)
Warrant Agreements
Cell Source, Inc.
Biotechnology
2020
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between Cell Source, Inc. and Purchasers (July 29, 2020)
Purchase Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Cell Source, Inc. 10% OID Convertible Promissory Note Due January 29, 2021
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Common Stock Purchase Warrant Agreement between Cell Source, Inc. and Purchaser (July 29, 2020)
Warrant Agreements
Cell Source, Inc.
Biotechnology
2020
Convertible Promissory Note between Cell Source, Inc. and Power Up Lending Group Ltd. dated January 10, 2020
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2020
Sixth Amendment to Research and Licence Agreement between Yeda Research and Development Company Ltd. and Cell Source Limited
License Agreements
Cell Source, Inc.
Biotechnology
2020
Cell Source, Inc. 8.0% Convertible Note Agreement with Darlene D. Soave (October 2019)
Note Agreements
Cell Source, Inc.
Biotechnology
NJ
2020
Cell Source, Inc. 2019 Equity Incentive Plan Stock Option Agreement with Yair Reisner
Warrant Agreements
Cell Source, Inc.
Biotechnology
NV
2019
Cell Source, Inc. 2019 Equity Incentive Plan Stock Option Agreement with Yair Reisner
Warrant Agreements
Cell Source, Inc.
Biotechnology
NV
2019
Cell Source, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Cell Source, Inc.
Biotechnology
NV
2019
Amendment No. 1 to Veto Cell Production and Clinical Trial Program Agreement between Cell Source Limited and The University of Texas M.D. Anderson Cancer Center
Modification Agreements
Cell Source, Inc.
Biotechnology
2019
Veto Cell Production and Clinical Trial Sponsorship Agreement between MD Anderson Cancer Center and Cell Source Limited
Collaboration Agreements
Cell Source, Inc.
Biotechnology
2019
Sponsored Research Agreement between The University of Texas M. D. Anderson Cancer Center and Cell Source
Collaboration Agreements
Cell Source, Inc.
Biotechnology
TX
2019
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2018
Fourth Amendment to Research and License Agreement between Yeda Research and Development Company Ltd. and Cell Source Ltd.
License Agreements
Cell Source, Inc.
Biotechnology
2018
Third Amendment to Research and License Agreement between Yeda Research and Development Company Limited and Cell Source Limited
License Agreements
Cell Source, Inc.
Biotechnology
2018
Second Amendment to Research and License Agreement between Yeda Research and Development Company Limited and Cell Source Limited
License Agreements
Cell Source, Inc.
Biotechnology
2018
Promissory Note between Cell Source, Inc. and Main Street Restaurant Associates Inc. dated May 10, 2016
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. $250,000 Convertible Note Due July 27, 2016 with Prodigious Wealth Limited
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. Convertible Note Agreement
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. Subscription Agreement for 10% Convertible Notes
Subscription Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. Warrant to Purchase 150,000 Shares of Common Stock
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Cell Source, Inc. Promissory Note and Subscription Agreement (March 8, 2016)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2016
Amendment and Waiver Agreement to Promissory Note between Cell Source, Inc. and Noteholder
Modification Agreements
Cell Source, Inc.
Biotechnology
2015
Cell Source, Inc. Warrant to Purchase Common Stock Agreement with David Zolty
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Cell Source, Inc. Warrant to Purchase Common Stock Agreement with Holder
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Cell Source, Inc. Promissory Note to David Zolty Dated July 20, 2015
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Cell Source, Inc. Convertible Promissory Note (2015)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Consulting/Advisory Agreement between Cell Source, Inc. and Dr. Terry B. Strom
Consulting Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Cell Source, Inc. Warrant to Purchase 250,000 Shares of Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Cell Source, Inc. Promissory Note Dated May 15, 2015
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Amendment to Promissory Notes between Cell Source, Inc. and Itamar Shimrat (June 2015)
Modification Agreements
Cell Source, Inc.
Biotechnology
2015
Cell Source, Inc. Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Cell Source, Inc. Promissory Note (March 2015)
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2015
Promissory Note between Cell Source, Inc. and Itamar Shimrat dated November 26, 2014
Note Agreements
Cell Source, Inc.
Biotechnology
NY
2014
Bridge Funding Agreement between Cell Source and Investor (David Zolty) dated October 23, 2013
Financing Agreements
Cell Source, Inc.
Biotechnology
2014
Third Amendment to Evaluation and Exclusive Option Agreement between Yeda Research and Development Company Ltd. and Cell Source Ltd.
Modification Agreements
Cell Source, Inc.
Biotechnology
2014
Amendment No. 1 to Registration Rights Agreement by and among Cell Source, Ltd., Cell Source, Inc., and Purchasers
Registration Rights Agreements
Cell Source, Inc.
Biotechnology
2014
Share Exchange Agreement between Ticket to See, Inc., Cell Source, Ltd., and Shareholders (June 30, 2014)
Exchange Agreements
Cell Source, Inc.
Biotechnology
NY
2014
Cell Source, Inc. Warrant to Purchase Common Stock (Warrant No. CS-1)
Warrant Agreements
Cell Source, Inc.
Biotechnology
2014
Warrant Agreement to Purchase Common Stock between Ticket to See, Inc. and Holder
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2014
Registration Rights Agreement between Cell Source, Ltd. and Purchasers
Registration Rights Agreements
Cell Source, Inc.
Biotechnology
NY
2014
Cell Source, Ltd. Subscription Agreement for Private Placement of Units
Subscription Agreements
Cell Source, Inc.
Biotechnology
NY
2014
Cell Source, Ltd. Warrant to Purchase Ordinary Shares Agreement
Warrant Agreements
Cell Source, Inc.
Biotechnology
NY
2014